Calumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +35.9%
- Free cash flow
- +450.7%
- Total debt
- −1.98%
Quarter to June 2026, against a year earlier
Follow CLMT
Alert me
Calumet, Inc. (CLMT) Revenue
Calumet, Inc.'s revenue for fiscal 2025 was $4.1B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $4.6B. Over the past ten years it has ranged from $2.3B (fiscal 2020) to $4.7B (fiscal 2022); the current reading is higher than 73% of that period. Calumet, Inc. ranks 17th of 58 Specialty Chemicals companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $4.1B | (1.25%) |
| FY2024 | $4.2B | 0.20% |
| FY2023 | $4.2B | (10.78%) |
| FY2022 | $4.7B | 48.87% |
| FY2021 | $3.1B | 38.79% |
| FY2020 | $2.3B | (34.30%) |
| FY2019 | $3.5B | (1.28%) |
| FY2018 | $3.5B | (7.08%) |
| FY2017 | $3.8B | 8.33% |
| FY2016 | $3.5B | (11.60%) |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $1.4B | 40.34% |
| Mar 2026 | $1.0B | (0.86%) |
| Dec 2025 | $1.0B | (3.65%) |
| Sep 2025 | $1.1B | 5.01% |
| 42 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| CLMT Calumet, Inc. | $4.6B |
| CBT Cabot Corporation compare | $3.7B |
| FUL H. B. Fuller Company compare | $3.6B |
| AVNT Avient Corporation compare | $3.4B |
| ASH Ashland Inc. compare | $1.9B |
| SXT Sensient Technologies Corporation compare | $1.7B |
| HWKN Hawkins, Inc. compare | $1.1B |
| PRM Perimeter Solutions, SA compare | $831.5M |
| WDFC WD-40 Company compare | $688.0M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on CLMT
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement